GENE ONLINE|News &
Opinion
Blog

2021-11-22|

Study Advocates Cautious Application of CRISPR in Designing Therapeutics

by Arvind C. Shekhar
Share To
CRISPR is a powerful technology that has enabled easy disruption of desired genes and has revolutionized the field of genome editing. CRISPR-based editing has been considered for various applications in medicine, but it also has its shortcomings such as off-target effects, generation of unexpected chromosomal alterations, or potential immunogenicity.

Studies have demonstrated that DSBs induced during CRISPR-based gene knockout can lead to a DNA damage response mediated by p53, a tumor-suppressor gene that initiates programmed cell death before the cells can become cancerous. Presently it is unclear whether p53 selection can happen broadly across multiple different cell types, and whether stronger p53 selection happens when certain genes or parts of the genome are targeted.

A recent study published in Nature Communications shows that CRISPR-Cas9 based gene-editing can confer a selective advantage to cells harboring mutations in genes associated with cancer irrespective of their cell types.

GO Prime with only $1.49 now

LATEST
World Vaccine Congress Washington 2025 Recap: Urgent Calls for Trust, Tech, and Global Access
2025-04-25
Astellas’ Transformation Journey: From Merger to Global Player, Betting on the Edge of Innovation and Risk?
2025-04-25
Roche Announces Massive 50 Billion Dollar Investment in the United States
2025-04-25
Steminent Stands Ready to Showcase Novel MSC-based Therapy for Spinocerebellar Ataxia at Global Stage
2025-04-24
Arkansas Medicaid Work Requirements Led to Coverage Loss for a Significant Number of Recipients
2025-04-24
Boehringer agrees new partnership to advance first-in-class precision cancer therapies
2025-04-24
Bristol Myers Squibb Schizophrenia Drug Fails Pivotal Test as an Add-On to Antipsychotics
2025-04-24
EVENT
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
2025-05-03
29th Taiwan Joint Cancer Conference 2025
Taipei, Taiwan
2025-05-05
Swiss Biotech Day 2025
Basel, Switzerland
2025-05-13
ASGCT 28th Annual Meeting 2025
New Orleans, U.S.A.
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
Scroll to Top